Opinion|Videos|August 1, 2024
Importance of Patient-Reported Outcomes
Author(s)Steven D. Nathan, MD
Steven Nathan, MD, continues a discussion surrounding the patient journey in through IPF treatment.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the potential impact of these novel treatments on disease progression, mortality, and patient-reported outcomes such as quality of life, survival time, and functional status?
- An important consideration in drug development is understanding the impact on patient-reported outcomes and quality of life. How are the clinical trials for idiopathic pulmonary fibrosis agents incorporating these measures?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
COVID-19 May Follow a Different Seasonal Pattern Than Influenza, RSV
2
Upcoming 2026-2027 Vaccine Season: Deals, Data, and an FDA Vote
3
House Passes Bill to Ease Medicare ACO Digital Quality Reporting Burden
4
Pediatric Cancer Carries Greater Financial Toxicity Than Adult Disease, Driving Calls for Systemic Change
5